Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-May 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5014797014 | Product containing precisely ropivacaine hydrochloride 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5014798016 | Ropivacaine hydrochloride 2 mg/mL solution for infusion and/or injection | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely ropivacaine hydrochloride 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | est un(e) (attribut) | Product containing only ropivacaine in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely ropivacaine hydrochloride 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | a une forme pharmaceutique (attribut) | Solution for infusion and/or injection | true | Inferred relationship | Some | ||
| Product containing precisely ropivacaine hydrochloride 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | Has precise active ingredient | Ropivacaine hydrochloride | true | Inferred relationship | Some | 1 | |
| Product containing precisely ropivacaine hydrochloride 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | Has basis of strength substance (attribute) | Ropivacaine hydrochloride | true | Inferred relationship | Some | 1 | |
| Product containing precisely ropivacaine hydrochloride 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | Has concentration strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely ropivacaine hydrochloride 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | Has concentration strength denominator unit | Milliliter (qualifier value) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely ropivacaine hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) | est un(e) (attribut) | True | Product containing precisely ropivacaine hydrochloride 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | Inferred relationship | Some | |
| Ropivacaine hydrochloride 2 mg/mL solution for infusion | est un(e) (attribut) | True | Product containing precisely ropivacaine hydrochloride 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR